Seroprevalence of HBsAg and Anti-HCV among HIV Positive Patients

Journal Title: Viral Hepatitis Journal - Year 2021, Vol 27, Issue 1

Abstract

Objectives: The study aimed to investigate the seroprevalence of hepatitis B surface antigen (HBsAg) and hepatitis C virus (anti- HCV) in human immunodeficiency virus (HIV) infected patients and to evaluate the results according to risk factors in our hospital in İstanbul, which was one of the centers where HIV-infected patients were followed up the most in our country. Materials and Methods: The medical files of 611 HIV-infected patients who were followed up in our infectious diseases and clinical microbiology outpatient clinic between 1999 and 2016, were analyzed to determine the seroprevalence of HBsAg and anti-HCV retrospectively. HIV-monoinfected patients, HIV+HBV-coinfected patients, and HIV+HCV-coinfected patients were examined separately in terms of demographic characteristics and risk factors, and compared with each other. Results: Of the patients 86.6% were male. The mean age of the patients was 37.0±11.2 (16-83). More than one-third of patients were 30-39 years old. Of the patients 43.7% were men who had sex with men (MSM). Of the patients, 5.8% were HBsAg-positive and 14.7% (236) of patients were positive for isolated anti-HBc IgG. The HBV-DNA positivity ratio was determined as 8.7% in the isolated anti-HBc IgG positive group. Of the patients 2% were anti-HCV positive, and 0.9% were HCV-RNA positive. The prevalence of HIV/ HCV coinfection was statistically significantly higher in intravenous (IV) drug users than HIV-monoinfected patients (p<0.001). Conclusion: It is not sufficient to evaluate HBsAg alone in HIVinfected individuals. Anti-HBc IgG and HBV-DNA should also be evaluated. Anti-HCV antibody must be tested especially in patients with IV drug addiction.

Authors and Affiliations

Meyha Şahin, Özlem Altuntaş Aydın, Hayat Kumbasar Karaosmanoğlu, Mustafa Yıldırım

Keywords

Related Articles

Evaluation of Health-Related Life Quality of Patients with Chronic Hepatitis Admitted to a Medical Faculty Hospital

Objectives: The aim of this study was to determine the life quality and related factors of patients with chronic hepatitis B and C who admitted to the Infectious Diseases Clinic of Erciyes University Medical Faculty Hosp...

The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy

Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, pat...

An Evaluation of Health Personnel Exposed to Occupational Injuries in Terms of HBV, HCV, and HIV Infections

Objectives: This study aims to determine the rates, distribution and risk factors of needle-stick and sharps injuries that cause diseases spread through blood and body fluids, to discuss relevant precautions, and to moni...

The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B

Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) level...

Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients

Objectives: The prevalence of hepatitis delta virus (HDV) worldwide shows geographical differences. Although there are several studies on anti-HDV seroprevalence rates in hepatitis B surface antigen (HBsAg)-positive pati...

Download PDF file
  • EP ID EP694436
  • DOI 10.4274/vhd.galenos.2020.2019.0043
  • Views 98
  • Downloads 0

How To Cite

Meyha Şahin, Özlem Altuntaş Aydın, Hayat Kumbasar Karaosmanoğlu, Mustafa Yıldırım (2021). Seroprevalence of HBsAg and Anti-HCV among HIV Positive Patients. Viral Hepatitis Journal, 27(1), -. https://www.europub.co.uk/articles/-A-694436